1. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability
    Nataly Naser Al Deen et al, 2019, Breast Cancer Metastasis and Drug Resistance CrossRef
  2. Intermittent Hypoxia Up-Regulates CCL2, RETN, and TNFα mRNAs in Adipocytes via Down-regulation of miR-452
    Tomoko Uchiyama et al, 2019, International Journal of Molecular Sciences CrossRef
  3. Identification and differential expression of microRNAs in Madin–Darby canine kidney cells with high and low tumorigenicities
    Jiamin Wang et al, 2022, Genes & Genomics CrossRef
  4. LncRNA MALAT1 induces colon cancer development by regulating miR‐129‐5p/HMGB1 axis
    Qiong Wu et al, 2018, Journal of Cellular Physiology CrossRef
  5. MiR-193a-5p serves as an inhibitor in ovarian cancer cells through RAB11A
    Yazhuo Wang et al, 2022, Reproductive Toxicology CrossRef
  6. Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer
    Fatemeh Khojasteh Poor et al, 2021, Breast Disease CrossRef
  7. Membrane trafficking alterations in breast cancer progression
    Andreia Ferreira et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
  8. LncRNA SNHG6 Induces Epithelial–Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944
    Dandan Mao et al, 2022, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  9. Variation in the co-expression profile highlights a loss of miRNA-mRNA regulation in multiple cancer types
    Gerardo Pepe et al, 2022, Non-coding RNA Research CrossRef
  10. NEAT1 contributes to breast cancer progression through modulating miR‐448 and ZEB1
    Xing Jiang et al, 2018, Journal of Cellular Physiology CrossRef
  11. Genetic variations in tumor-suppressor miRNA-encoding genes and their target genes: focus on breast cancer development and possible therapeutic strategies
    Yogita Chhichholiya et al, 2023, Clinical and Translational Oncology CrossRef
  12. Construction of ceRNA network and identification of hub differentially expressed genes associated with breast cancer using reanalysis of microarray dataset: A systems biology approach
    Lina Moallemi Rad et al, 2023, Pathology - Research and Practice CrossRef
  13. miR‐452 promotes cell metastasis and the epithelial to mesenchymal by targeting SOX7 in clear‐cell renal‐cell carcinoma
    Feng Liu et al, 2019, Journal of Cellular Biochemistry CrossRef
  14. Multiple functions and dual characteristics of RAB11A in cancers
    Rui-Jian Guo et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  15. MiR‐577 suppresses epithelial‐mesenchymal transition and metastasis of breast cancer by targeting Rab25
    Chonggao Yin et al, 2018, Thoracic Cancer CrossRef
  16. MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer
    Santosh Lamichhane et al, 2021, Inflammation Research CrossRef
  17. Extracellular vesicles derived from Wharton’s Jelly mesenchymal stem cells inhibit the tumor environment via the miR-125b/HIF1α signaling pathway
    Yun-Hsuan Chang et al, 2022, Scientific Reports CrossRef
  18. Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network
    Guangle Zhang et al, 2018, PLOS ONE CrossRef
  19. The relationship between microRNAs and Rab family GTPases in human cancers
    Arman Shahabi et al, 2019, Journal of Cellular Physiology CrossRef
  20. The Impact of microRNAs in Breast Cancer Angiogenesis and Progression
    Emmanuel N. Kontomanolis et al, 2019, MicroRNA CrossRef
  21. MicroRNA-532 exerts oncogenic functions in t(4;14) multiple myeloma by targeting CAMK2N1
    Kaihong Xu et al, 2019, Human Cell CrossRef
  22. MicroRNA-452: a double-edged sword in multiple human cancers
    Fateme Karimi Dermani et al, 2023, Clinical and Translational Oncology CrossRef
  23. GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling
    Aleena K. S. Arakaki et al, 2018, International Journal of Molecular Sciences CrossRef
  24. miR-452 promotes the development of gastric cancer via targeting EPB41L3
    Xiaobo He et al, 2020, Pathology - Research and Practice CrossRef
  25. TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer
    María Paz Saldías et al, 2021, Frontiers in Oncology CrossRef
  26. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway
    Yunxia Zhang et al, 2020, Cancer Cell International CrossRef